Reduced Cancer Drug Reimbursements Don’t Impede Access – JAMA Study
This article was originally published in The Pink Sheet Daily
2003-2006 Medicare claim review finds no evidence that lowering physician payments adversely affected access to care.
You may also be interested in...
The Medicare program is earmarking $300 mil. for a "quality of care" demonstration project that should help smooth the transition to ASP-based reimbursement in 2005
Elizabeth Fowler brings combination of Capitol Hill, White House and pharma industry experience to the role of director of the Center for Medicare and Medicaid Innovation.
Policymakers should instead focus on increasing efficiencies in drug development, distribution and reimbursement, National Academies report says, while also seeking broad policies like HHS direct negotiation for drug prices in Medicare.